Your browser doesn't support javascript.
loading
[Cell metabolomics study of ginkgo flavone aglycone combined with doxorubicin against liver cancer in synergy].
Lu, Yuan; Wang, Yan-Li; Song, Zhong-Jun; Zhu, Xiao-Qing; Liu, Chun-Hua; Chen, Ji-Yu; Li, Yong-Jun; He, Yan.
Afiliação
  • Lu Y; Clinical Trial Research Center, the Affiliated Hospital of Guizhou Medical University Guiyang 550001, China Provincial Key Laboratory of Pharmaceutics in Guizhou Province, State Key Laboratory of Functions and Applications of Medicinal Plants,Guizhou Medical University Guiyang 550004, China.
  • Wang YL; School of Pharmaceutical Sciences, Guizhou Medical University Guiyang 550004, China.
  • Song ZJ; School of Pharmaceutical Sciences, Guizhou Medical University Guiyang 550004, China.
  • Zhu XQ; School of Pharmaceutical Sciences, Guizhou Medical University Guiyang 550004, China.
  • Liu CH; Engineering Research Center for the Development and Application of Ethnic Medicine and Traditional Chinese Medicine (Ministry of Education), Guizhou Medical University Guiyang 550004, China.
  • Chen JY; Clinical Trial Research Center, the Affiliated Hospital of Guizhou Medical University Guiyang 550001, China.
  • Li YJ; Engineering Research Center for the Development and Application of Ethnic Medicine and Traditional Chinese Medicine (Ministry of Education), Guizhou Medical University Guiyang 550004, China.
  • He Y; Clinical Trial Research Center, the Affiliated Hospital of Guizhou Medical University Guiyang 550001, China.
Zhongguo Zhong Yao Za Zhi ; 47(18): 5040-5051, 2022 Sep.
Article em Zh | MEDLINE | ID: mdl-36164914

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Ginkgo biloba / Flavonas / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Ginkgo biloba / Flavonas / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China